2nd Annual MarketsandMarkets

Infectious Disease Diagnostics and Point-Of-Care Testing Virtual Conference (Eastern Standard Time)

11th and 12th March 2021

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised, and accurate.

Point-of-care testing (POCT) is a growing testing. Today, you may see POCT in a hospital with handheld gadgets or small testers in emergency department, extensive care setting, popular clinical wards, and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.

In the era of improved diagnostics, our 2nd Annual Virtual Event on Infectious Disease Diagnostics and Point-Of-Care Testing will serve as a networking place for Diagnostics professional, Industrial specialists, and solution providers to address the rising innovation in its discipline and the way it can be used as disease prevention tool.

WHAT TO EXPECT

  • Rapid Screening of Infectious Diseases
  • Microarray technology for diagnostics
  • Application of Point-Of-Care in disease outbreak
  • Advancement of technologies in microbiology and its clinical application
  • Sepsis Detection and its challenges
  • POCT in critical care and applications in patient monitoring

  • Learn about innovative devices and procedures for effective diagnostics 
  • Meet global heads of diagnostics from the industry and Academics
  • 100+ POCT professionals attending
  • Access to online presentations on-demand post-summit
  • Case studies presented from leading technology collaborations 
  • Interactive panel discussions

Hospitals/Universities/Labs

Hospitals- Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department

Designation- Senior scientist, scientist, Microbiologist, biologists, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors, POCT coordinators

Pharma/Therapeutics

Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA

Online registrations

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

Dr Pedro Estrela

Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath

09:00 - 09:10

PATHOGENS DETECTION NEEDS AT POINT OF CARE

Biosensors and lab-on-chip devices for cancer diagnosis and management

Dr Pedro Estrela

Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath

09:10 - 09:40

The pros and cons of point of care testing for COVID-19 virus: virus, antigens and antibodies

Alan Wu

Alan Wu, San Francisco General Hospital, USA, Clinical Chemistry and Toxicology

09:40 - 10:10

How the COVID-19 Exposes the Flaws of Current HealthTesting – Hypermobility & Microfluidics for Health 4.0 Tools for new Medicine

Dr. Ali Tinazli

Dr. Ali Tinazli, Chief Commercial Officer , Fluxergy, USA

10:10 - 10:40

CLINICAL APPLICATIONS OF POINT-OF-CARE TOWARDS INFECTIOUS DISEASES

Application of Point-Of-Care in disease outbreak

Nicola Hodges

Nicola Hodges , Point of Care Coordinator , Royal United Hospitals Bath NHS Foundation Trust, UK

10:40 - 11:10

Critical needs of reagents and assay kits to fight COVID-19 and SARS-CoV-2 variants

Dr. Prajwal Paudel

Dr. Prajwal Paudel , Product Development Scientist , ACROBiosystems,USA

11:10 - 11:40

Blockchain-backed participatory research model for rapid customization of an open Lab on a Chip platform towards emerging challenges in point-of-care diagnostics

Jens Ducree

Jens Ducree, Professor of Microsystems in the School of Physical Sciences, Dublin City University (DCU)

11:40 - 12:10

Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer™ Technology

Dwight Egan

Dwight Egan, Chief Executive Officer, Co-Diagnostics, Inc

12:10 - 12:40

SARS-CoV-2 & Seasonal Influenza Lateral Flow Multiplex Assays For Point Of Care Or At Home Diagnostic Products

David Alan Zarling

David Alan Zarling, Executive Chairman and Co-Founder, OptiSomix Incorporated

12:40 - 13:10

Closing remarks from the Chairman

13:10 - 13:15

One-to-One networking break| End of Day 1

13:15 - 13:15

Online registrations

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

Robert H. Christenson

Robert H. Christenson, Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA

09:00 - 09:10

POCT IN CRITICAL CARE

Keynote presentation- Training, competency assessment, and maintaining competency of POC users

Robert H. Christenson

Robert H. Christenson, Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA

09:10 - 09:40

COVID-19 – Pandemic. Managing COVID-19 Respiratory Distress Patients Using an Expanded Test Critical Care Analyzer

Germano Ferrari

Germano Ferrari , Director of Medical and Scientific Affairs(Europe) , NOVA Biomedical,UK

09:40 - 10:10

Reducing Errors at Point-Of-Care

Uchenna Okeahialam

Uchenna Okeahialam, Advanced Biomedical Scientist (POCT), Airedale and Bradford Hospitals Integrated Pathology Solutions, UK

10:10 - 10:40

Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale

Vania Silverio

Vania Silverio , R&D Microfluidics Scientist , INESC-MN, Portugal

10:40 - 11:10

PATIENT MONITORING USING POCT

POCT for covid testing and how it has improved during the pandemic?

Reshma Kadave

Reshma Kadave, Biomedical Scientist & Senior IT Analyst, Imperial College Healthcare NHS Trust, UK

11:10 - 11:40

Factors leading to the increase in demand for poct tech and challenges in upholding Quality Standards

Jyoti Chandok

Jyoti Chandok, Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre, Canada

11:40 - 12:10

Introduction of galactomannan testing in-house to aid in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA)

Hannah Lowe

Hannah Lowe, Clinical Scientist , East Kent Hospitals University NHS Foundation Trust, UK

12:10 - 12:40

Closing remarks from the Chairman

12:40 - 12:45

One-to-One networking break | End of conference

12:45 - 12:45

SPEAKERS

Jyoti Chandok

Jyoti Chandok

Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre

Pedro Estrela

Pedro Estrela

Director C3Bio - Centre for Biosensors, Bioelectronics and Biodevices, University of Bath, UK

Uchenna Okeahialam

Uchenna Okeahialam

Advanced Biomedical Scientist (POCT), Airedale and Bradford Hospitals Integrated Pathology Solutions, UK

Hannah Lowe

Hannah Lowe

Clinical Scientist , East Kent Hospitals University NHS Foundation Trust, UK

Vania Silverio

Vania Silverio

R&D Microfluidics Scientist , INESC-MN, Portugal

Germano Ferrari

Germano Ferrari

Director of Medical and Scientific Affairs(Europe) , NOVA Biomedical,UK

Dr. Ali Tinazli

Dr. Ali Tinazli

Chief Commercial Officer , Fluxergy, USA

Robert H. Christenson

Robert H. Christenson

Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA

Dr. Prajwal Paudel

Dr. Prajwal Paudel

Product Development Scientist , ACROBiosystems,USA

Dwight Egan

Dwight Egan

Chief Executive Officer, Co-Diagnostics, Inc

Nicola Hodges

Nicola Hodges

Point of Care Coordinator , Royal United Hospitals Bath NHS Foundation Trust, UK

SPONSORS

PARTNERS